Latest Immutep (ASX:IMM) News
Page 1
Page 1 of 4
Market Wrap - Week 44 (26 Oct -> 30 Oct) 2026
31 Oct 2026
Healthcare Wrap - Week 44 (26 Oct -> 30 Oct) 2026
31 Oct 2026
Immutep shifts efti strategy after manufacturing differences surface in failed trial
29 Oct 2026
Immutep’s FY26 loss widens as failed lung cancer trial reshapes the pipeline
27 Oct 2026
Immutep’s failed Phase III trial leaves manufacturing questions and a shorter cash runway
26 Oct 2026
Market Wrap - Week 37 (7 Sept -> 11 Sept) 2026
12 Sept 2026
Healthcare Wrap - Week 37 (7 Sept -> 11 Sept) 2026
12 Sept 2026
Immutep Pins Efti Reset on Manufacturing Differences After TACTI-004 Failure
11 Sept 2026
Healthcare Wrap - Week 29 (13 July -> 17 July) 2026
18 July 2026
Immutep Reports Mature 30.9-Month Survival in 1L NSCLC but TACTI-004 Trial Halted
13 July 2026
Market Wrap - Week 16 (13 Apr -> 17 Apr) 2026
18 Apr 2026
Healthcare Wrap - Week 16 (13 Apr -> 17 Apr) 2026
18 Apr 2026